About us

Objectives

Image of FFPE blocks in storage at the HCB

  • Provide high quality tissue samples and services
  • Develop new techniques to support cancer research
  • Develop models to become self-sustaining
  • Provide valuable resources now and into the future

Operation and Governance

The Hunter Cancer Biobank (HCB) operates to the highest of standards.  The HCB is governed by a Management Committee including members that represent the research and pathology needs of all cancer researchers. The aim of the HCB MC is to ensure the development and ongoing function of a comprehensive, validated, well annotated cancer biobank to provide cancer researchers with fast, easy access to high quality patient samples linked to clinical outcomes. The Management Committee reports to the Hunter Cancer Research Alliance (HCRA) Director and Executive Committee.

HCB Operational Chart (108KB)

The HCB has ethical approval from the Hunter New England Human Research Ethics Committee and all HCB activities are aligned with best practice standards.

Our Partners

The Hunter Cancer Biobank works in collaboration with a number of partners without whom the biobank would be unable to provide quality biospecimens for research.

The HCB has been established through the Hunter Cancer Research Alliance and works in partnerships with the Hunter Medical Research Institute and University of Newcastle who provide the biobank with space and facilities. Pathology North is integral to acquisition of biospecimens while working with the Calvary Mater Newcastle and Hunter New England Health provides the biobank access to collaborating clinicians and patients willing to donate specimens.

The University of Newcastle, Australia Hunter New England Local Health District Calvary Mater Newcastle Hunter Medical Research Institute Cancer Institute NSW Pathology North